[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] [@jmatlus](/creator/twitter/jmatlus) "$MRNA is waking up. Moderna just dropped data that could redefine the flu-vaccine market. 🧬 mRNA-1010 (seasonal flu) = XXXX% higher efficacy than current standard-dose vaccines. 🦠mRNA-1018 (H5 pandemic flu) = XXXX% protective response after just two doses. This isnt another COVID replay its Modernas second act. From pandemic hero to multi-vaccine powerhouse scaling faster than $PFE $BNTX or $NVAX ever did. 💥 Seasonal flu dominance. 💥 Pandemic preparedness edge. 💥 mRNA platform advantage rapid strain updates lower dev time global scalability. The biotech rotation is coming. Smart money" [X Link](https://x.com/jmatlus/status/1979886718430916616) [@jmatlus](/creator/x/jmatlus) 2025-10-19T12:25Z XXX followers, 1235 engagements "Moderna ($MRNA) dropped a solid pipeline update today focusing beyond Covid cancer rare diseases new vax tech etc. No hype yet no big upgrades. Thats how smart money plays it. Once it runs XX% youll suddenly see analyst confidence and headlines everywhere. $MRNA $PFE $LLY $AMGN $NVDA $TSLA $AAPL $MSFT $GOOGL" [X Link](https://x.com/jmatlus/status/1980318881983189125) [@jmatlus](/creator/x/jmatlus) 2025-10-20T17:03Z XXX followers, XXX engagements "$MRNA quietly expanding beyond Covid. Cancer flu and rare disease programs now in motion. No hype. No upgrades. Just silence from the big houses. Once its up XX% theyll call it a turnaround story. Smart eyes accumulate when the street sleeps. $MRNA $PFE $LLY $AMGN $JNJ $NVDA $AAPL $MSFT $GOOGL" [X Link](https://x.com/jmatlus/status/1980319053156589762) [@jmatlus](/creator/x/jmatlus) 2025-10-20T17:03Z XXX followers, XXX engagements "$EICHERMOT.NS Valuation stretched GST turns headwind 🚨 Indias new GST slabs flip the script for Royal Enfield. XXX cc: GST cut to XX % XX % cheaper XXX cc: GST hiked to XX % XX % costlier August 2025 data: XXX cc XXXX k units (+61 % YoY) XXX cc XXXX k units (+23 % YoY) High-margin XXX / XXX cc models may see XX % volume hit erasing gains from cheaper XXX cc bikes. Premium XXX cc = XX % volume but XX % profit. GST XXX margin compression slower EPS growth ( XX %). Stock trades at XX P/E already pricing 2025 % CAGR. If it de-rates to XX 2025 % downside possible. Until exports or a new platform" [X Link](https://x.com/jmatlus/status/1979905900669174084) [@jmatlus](/creator/x/jmatlus) 2025-10-19T13:42Z XXX followers, XX engagements "Avg Royal Enfield XXX sells X L ex-showroom. At XX % margin XX k profit per bike. With stock at XX P/E market values each XX k profit at XX L X the selling price Thats a consumer-brand multiple on a cyclical auto business. Even a small margin slip or XX % GST-led slowdown in XXX cc sales can break this equation fast. #EicherMotors $EICHERMOT #RoyalEnfield #AutoStocks #GST #IndiaMarkets $TATAMOTORS $MARUTI $BAJAJ-AUTO $TVSMOTOR $HEROMOTOCO $M&M" [X Link](https://x.com/jmatlus/status/1979906328102322600) [@jmatlus](/creator/x/jmatlus) 2025-10-19T13:43Z XXX followers, XX engagements "The line between biotech and tech is fading fast. $MRNAs new mRNA platform is as much about data and AI as biology. Todays quiet move might be tomorrows next $NVDA-style run. $MRNA $NVDA $AMD $SMCI $MSFT $GOOG $META $LLY $REGN $ABBV" [X Link](https://x.com/jmatlus/status/1980319790943334528) [@jmatlus](/creator/x/jmatlus) 2025-10-20T17:06Z XXX followers, XX engagements "Biotech + AI convergence is getting real. $MRNAs next-gen trials $LLYs data platform $NVDAs bio-foundry stack all pointing the same way. The next breakout wont be hype itll be data-backed. $MRNA $LLY $NVDA $AMZN $GOOG $MSFT $META" [X Link](https://x.com/jmatlus/status/1980320761769500707) [@jmatlus](/creator/x/jmatlus) 2025-10-20T17:10Z XXX followers, XXX engagements "No analyst upgrades no noise $MRNA moving slow and silent. Big funds often build before they talk. Watch volumes not just the news. $MRNA $PFE $AZN $AMGN $ABBV $NVDA $AAPL $MSFT" [X Link](https://x.com/jmatlus/status/1980320837434765420) [@jmatlus](/creator/x/jmatlus) 2025-10-20T17:10Z XXX followers, XXX engagements "Everyone ignoring $MRNA now but the company just dropped key pipeline moves beyond Covid cancer RSV rare diseases. No hype yet. Big funds usually wake up after the first XX% move. Classic quiet-phase accumulation. Watch the crossover of biotech + AI + data in the next leg. $MRNA $BMY $REGN $AZN $ABBV $META $AMD $INTC $GOOG" [X Link](https://x.com/jmatlus/status/1980319215828758649) [@jmatlus](/creator/x/jmatlus) 2025-10-20T17:04Z XXX followers, XX engagements "$MRNA quietly pushing a deeper pipeline beyond Covid cancer flu RSV rare diseases and new mRNA platforms. No noise. No upgrades. Just silent accumulation. Once its up XX% youll see analyst confidence and media hype everywhere. Early phase for those who read between the lines. $MRNA $PFE $LLY $BMY $AMGN $REGN $AZN $ABBV $GILD $VRTX $NVDA $TSLA $AAPL $MSFT $GOOGL $META $AMZN $NFLX $INTC $AVGO $SMCI" [X Link](https://x.com/jmatlus/status/1980319436931252243) [@jmatlus](/creator/x/jmatlus) 2025-10-20T17:05Z XXX followers, XX engagements "Everyone hunts hype. Real investors hunt silence. $MRNA just expanded beyond Covid into cancer and rare diseases. No spotlight yet but the blueprint for a rebound is right there. $MRNA $BMY $AMGN $LLY $ABBV $NVDA $AAPL $MSFT $META $GOOG" [X Link](https://x.com/jmatlus/status/1980319732462239781) [@jmatlus](/creator/x/jmatlus) 2025-10-20T17:06Z XXX followers, XXX engagements "$MRNA pipeline quietly expanding into oncology flu and rare disease programs. No noise yet but the direction looks strong. Institutions usually move before the headlines. $MRNA $LLY $BMY $AMGN $NVDA $MSFT $GOOGL" [X Link](https://x.com/jmatlus/status/1980320675299831963) [@jmatlus](/creator/x/jmatlus) 2025-10-20T17:10Z XXX followers, XX engagements "Todays focus turning to pharma innovation again. $MRNA pipeline shift + $LLYs obesity run + $BMY cancer trials healthcare is quietly resetting leadership. $MRNA $LLY $BMY $AMGN $ABBV $REGN $TSLA $NVDA $GOOGL" [X Link](https://x.com/jmatlus/status/1980327177985065242) [@jmatlus](/creator/x/jmatlus) 2025-10-20T17:36Z XXX followers, XX engagements "Every big story begins in silence. $MRNA is writing one now moving beyond Covid building long-term assets. Patience pays noise comes later. $MRNA $PFE $BNTX $LLY $BMY $AZN $AMZN $MSFT $META $NVDA" [X Link](https://x.com/jmatlus/status/1980327779246948425) [@jmatlus](/creator/x/jmatlus) 2025-10-20T17:38Z XXX followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@jmatlus
"$MRNA is waking up. Moderna just dropped data that could redefine the flu-vaccine market. 🧬 mRNA-1010 (seasonal flu) = XXXX% higher efficacy than current standard-dose vaccines. 🦠mRNA-1018 (H5 pandemic flu) = XXXX% protective response after just two doses. This isnt another COVID replay its Modernas second act. From pandemic hero to multi-vaccine powerhouse scaling faster than $PFE $BNTX or $NVAX ever did. 💥 Seasonal flu dominance. 💥 Pandemic preparedness edge. 💥 mRNA platform advantage rapid strain updates lower dev time global scalability. The biotech rotation is coming. Smart money"
X Link @jmatlus 2025-10-19T12:25Z XXX followers, 1235 engagements
"Moderna ($MRNA) dropped a solid pipeline update today focusing beyond Covid cancer rare diseases new vax tech etc. No hype yet no big upgrades. Thats how smart money plays it. Once it runs XX% youll suddenly see analyst confidence and headlines everywhere. $MRNA $PFE $LLY $AMGN $NVDA $TSLA $AAPL $MSFT $GOOGL"
X Link @jmatlus 2025-10-20T17:03Z XXX followers, XXX engagements
"$MRNA quietly expanding beyond Covid. Cancer flu and rare disease programs now in motion. No hype. No upgrades. Just silence from the big houses. Once its up XX% theyll call it a turnaround story. Smart eyes accumulate when the street sleeps. $MRNA $PFE $LLY $AMGN $JNJ $NVDA $AAPL $MSFT $GOOGL"
X Link @jmatlus 2025-10-20T17:03Z XXX followers, XXX engagements
"$EICHERMOT.NS Valuation stretched GST turns headwind 🚨 Indias new GST slabs flip the script for Royal Enfield. XXX cc: GST cut to XX % XX % cheaper XXX cc: GST hiked to XX % XX % costlier August 2025 data: XXX cc XXXX k units (+61 % YoY) XXX cc XXXX k units (+23 % YoY) High-margin XXX / XXX cc models may see XX % volume hit erasing gains from cheaper XXX cc bikes. Premium XXX cc = XX % volume but XX % profit. GST XXX margin compression slower EPS growth ( XX %). Stock trades at XX P/E already pricing 2025 % CAGR. If it de-rates to XX 2025 % downside possible. Until exports or a new platform"
X Link @jmatlus 2025-10-19T13:42Z XXX followers, XX engagements
"Avg Royal Enfield XXX sells X L ex-showroom. At XX % margin XX k profit per bike. With stock at XX P/E market values each XX k profit at XX L X the selling price Thats a consumer-brand multiple on a cyclical auto business. Even a small margin slip or XX % GST-led slowdown in XXX cc sales can break this equation fast. #EicherMotors $EICHERMOT #RoyalEnfield #AutoStocks #GST #IndiaMarkets $TATAMOTORS $MARUTI $BAJAJ-AUTO $TVSMOTOR $HEROMOTOCO $M&M"
X Link @jmatlus 2025-10-19T13:43Z XXX followers, XX engagements
"The line between biotech and tech is fading fast. $MRNAs new mRNA platform is as much about data and AI as biology. Todays quiet move might be tomorrows next $NVDA-style run. $MRNA $NVDA $AMD $SMCI $MSFT $GOOG $META $LLY $REGN $ABBV"
X Link @jmatlus 2025-10-20T17:06Z XXX followers, XX engagements
"Biotech + AI convergence is getting real. $MRNAs next-gen trials $LLYs data platform $NVDAs bio-foundry stack all pointing the same way. The next breakout wont be hype itll be data-backed. $MRNA $LLY $NVDA $AMZN $GOOG $MSFT $META"
X Link @jmatlus 2025-10-20T17:10Z XXX followers, XXX engagements
"No analyst upgrades no noise $MRNA moving slow and silent. Big funds often build before they talk. Watch volumes not just the news. $MRNA $PFE $AZN $AMGN $ABBV $NVDA $AAPL $MSFT"
X Link @jmatlus 2025-10-20T17:10Z XXX followers, XXX engagements
"Everyone ignoring $MRNA now but the company just dropped key pipeline moves beyond Covid cancer RSV rare diseases. No hype yet. Big funds usually wake up after the first XX% move. Classic quiet-phase accumulation. Watch the crossover of biotech + AI + data in the next leg. $MRNA $BMY $REGN $AZN $ABBV $META $AMD $INTC $GOOG"
X Link @jmatlus 2025-10-20T17:04Z XXX followers, XX engagements
"$MRNA quietly pushing a deeper pipeline beyond Covid cancer flu RSV rare diseases and new mRNA platforms. No noise. No upgrades. Just silent accumulation. Once its up XX% youll see analyst confidence and media hype everywhere. Early phase for those who read between the lines. $MRNA $PFE $LLY $BMY $AMGN $REGN $AZN $ABBV $GILD $VRTX $NVDA $TSLA $AAPL $MSFT $GOOGL $META $AMZN $NFLX $INTC $AVGO $SMCI"
X Link @jmatlus 2025-10-20T17:05Z XXX followers, XX engagements
"Everyone hunts hype. Real investors hunt silence. $MRNA just expanded beyond Covid into cancer and rare diseases. No spotlight yet but the blueprint for a rebound is right there. $MRNA $BMY $AMGN $LLY $ABBV $NVDA $AAPL $MSFT $META $GOOG"
X Link @jmatlus 2025-10-20T17:06Z XXX followers, XXX engagements
"$MRNA pipeline quietly expanding into oncology flu and rare disease programs. No noise yet but the direction looks strong. Institutions usually move before the headlines. $MRNA $LLY $BMY $AMGN $NVDA $MSFT $GOOGL"
X Link @jmatlus 2025-10-20T17:10Z XXX followers, XX engagements
"Todays focus turning to pharma innovation again. $MRNA pipeline shift + $LLYs obesity run + $BMY cancer trials healthcare is quietly resetting leadership. $MRNA $LLY $BMY $AMGN $ABBV $REGN $TSLA $NVDA $GOOGL"
X Link @jmatlus 2025-10-20T17:36Z XXX followers, XX engagements
"Every big story begins in silence. $MRNA is writing one now moving beyond Covid building long-term assets. Patience pays noise comes later. $MRNA $PFE $BNTX $LLY $BMY $AZN $AMZN $MSFT $META $NVDA"
X Link @jmatlus 2025-10-20T17:38Z XXX followers, XXX engagements
/creator/twitter::1532317872407576576/posts